A recent study conducted at Tel Aviv University has devised a large mechanical system that operates under dynamical rules akin to those found in quantum systems. The dynamics of quantum systems, composed of microscopic particles like atoms or electrons, are notoriously difficult, if not impossible, to observe directly.
However, this new system allows researchers to visualize phenomena occurring in specialized “topological” materials through the movement of a system of coupled pendula.
The research is a collaboration between Dr. Izhar Neder of the Soreq Nuclear Research Center, Chaviva Sirote-Katz of the Department of Biomedical Engineering, Dr. Meital Geva and Prof. Yair Shokef of the School of Mechanical Engineering, and Prof. Yoav Lahini and Prof. Roni Ilan of the School of Physics and Astronomy at Tel Aviv University and was recently published in the Proceedings of the National Academy of Sciences.
A recent study conducted at Tel Aviv University has devised a large mechanical system that operates under dynamical rules akin to those found in quantum systems. The dynamics of quantum systems, composed of microscopic particles like atoms or electrons, are notoriously difficult, if not impossible, to observe directly.
However, this new system allows researchers to visualize phenomena occurring in specialized “topological” materials through the movement of a system of coupled pendula.
The research is a collaboration between Dr. Izhar Neder of the Soreq Nuclear Research Center, Chaviva Sirote-Katz of the Department of Biomedical Engineering, Dr. Meital Geva and Prof. Yair Shokef of the School of Mechanical Engineering, and Prof. Yoav Lahini and Prof. Roni Ilan of the School of Physics and Astronomy at Tel Aviv University and was recently published in the Proceedings of the National Academy of Sciences.
A recent study conducted at Tel Aviv University has devised a large mechanical system that operates under dynamical rules akin to those found in quantum systems. The dynamics of quantum systems, composed of microscopic particles like atoms or electrons, are notoriously difficult, if not impossible, to observe directly.
However, this new system allows researchers to visualize phenomena occurring in specialized “topological” materials through the movement of a system of coupled pendula.
The research is a collaboration between Dr. Izhar Neder of the Soreq Nuclear Research Center, Chaviva Sirote-Katz of the Department of Biomedical Engineering, Dr. Meital Geva and Prof. Yair Shokef of the School of Mechanical Engineering, and Prof. Yoav Lahini and Prof. Roni Ilan of the School of Physics and Astronomy at Tel Aviv University and was recently published in the Proceedings of the National Academy of Sciences.
A recent study conducted at Tel Aviv University has devised a large mechanical system that operates under dynamical rules akin to those found in quantum systems. The dynamics of quantum systems, composed of microscopic particles like atoms or electrons, are notoriously difficult, if not impossible, to observe directly.
However, this new system allows researchers to visualize phenomena occurring in specialized “topological” materials through the movement of a system of coupled pendula.
The research is a collaboration between Dr. Izhar Neder of the Soreq Nuclear Research Center, Chaviva Sirote-Katz of the Department of Biomedical Engineering, Dr. Meital Geva and Prof. Yair Shokef of the School of Mechanical Engineering, and Prof. Yoav Lahini and Prof. Roni Ilan of the School of Physics and Astronomy at Tel Aviv University and was recently published in the Proceedings of the National Academy of Sciences.
In a collaboration with Kyushu University, a team of Harvard University scientists says their new research into the ability to regrow lost limbs sets the stage’ for proper limb regeneration.
Of course, some animals, including amphibians, can regrow a lost arm or leg, but the team behind this latest research hopes to bring that ability to humans who hope to regrow lost limbs.
The researchers also say this process could facilitate the growing of limbs in animals that lost them to evolution, such as snakes.
Cancer survivor, Gail Baron Simpson, shares her personal journey to treatment success in this in-depth interview with Precision Oncology specialist and CTOAM co-founder, Alex Rolland, and Michelle Morand, Precision Cancer Medicine Advocacy specialist and CTOAM co-founder.
Please watch our short intro video to Gail’s story first! 👉 • Introduction to Gail’s Incredible Can…
After being diagnosed with a rare orphan cancer, Gail discusses her experience with navigating the challenges of standard healthcare and her decision to hire CTOAM to help integrate Precision Cancer Medicine into her cancer care – and how she was able to advocate for the right treatment and eventually find success.
Join us for an extraordinary livestream webinar, ‘Paving the Way for the Future: Learning from 4 Biostasis Cases and the Challenges and Advancements at Tomorrow Bio’ featuring esteemed speakers Dr. Emil Kendziorra and Dr. Irishikesh Santhosh from Tomorrow Biostasis GmbH. This pivotal session, scheduled for March 18th, 2024, at 7:00 PM, will delve into the latest advancements and real-world applications of biostasis, focusing on the detailed processes and outcomes associated with four distinct patient cases from 2023.
In this webinar, we will explore the intricate procedures and challenges encountered during the biostasis process, including stabilization in the face of cardiopulmonary arrest, the nuances of surgical and perfusion procedures, and the critical cooldown process for long-term storage. Our experts will unpack the innovative techniques employed, the utilization of cryoprotectant solutions, cooling techniques, and the diligent monitoring through CT scans, alongside the resolution of unforeseen technical challenges.
Each case report offers a unique glimpse into the complexities of biostasis, presenting the issues faced, such as equipment malfunctions and procedural hurdles, and the subsequent strategies for resolution or planned mitigations. Through graphical presentations on temperature, pressure, and refractive index, and detailed analyses of CT scans, attendees will gain comprehensive insights into the cutting-edge methods and equipment pivotal to biostasis.
This webinar is not just a learning opportunity but a platform for interactive discussion. We encourage all attendees to engage with our speakers through live questions, share their insights, and participate in real-time polls. Whether you’re a seasoned medical professional, an avid student of science, or simply fascinated by the potential of biostasis to preserve life, this session promises to be both enlightening and engaging.
A computational model of the more than 26 million atoms in a DNA-packed viral capsid expands our understanding of virus structure and DNA dynamics, insights that could provide new research avenues and drug targets, University of Illinois Urbana-Champaign researchers report in the journal Nature.
“To fight a virus, we want to know everything there is to know about it. We know what’s inside in terms of components, but we don’t know how they’re arranged,” said study leader Aleksei Aksimentiev, an Illinois professor of physics. “Knowledge of the internal structures gives us more targets for drugs, which tend to focus on receptors on the surface or replication proteins.”
Viruses keep their genetic material —either DNA or RNA—packaged in a hollow particle called a capsid. While the structures of many hollow capsids have been described, the structure of a full capsid and the genetic material inside it has remained elusive.
The first UK patients received the experimental mRNA therapy – a type of immunotherapy treatment called mRNA-4359 – at Imperial College Healthcare NHS Trust as part of a phase 1/2 clinical trial. The trial aims to evaluate its safety and potential for treating melanoma, lung cancer and other ‘solid tumour’ cancers.
The treatment is designed using messenger RNA (mRNA) and works by presenting common markers of tumours to the patient’s immune system. This should help to train patients’ immune systems to recognise and fight cancer cells expressing these markers, but also potentially eliminate cells that may suppress the immune response.
